Evidence map›Paper›PMID 40559565›Full record

SynthesisPathogens (Basel, Switzerland)2025

Global Epidemiology and Antimicrobial Resistance of Metallo-β-Lactamase (MBL)-Producing Acinetobacter Clinical Isolates: A Systematic Review.

Matthew E Falagas, Dimitrios S Kontogiannis, Maria Zidrou, Charalampos Filippou, Giannoula S Tansarli

Abstract readSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Pathogens (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Antibiotics for Rheumatologic Diseases: A Critical Review.International journal of molecular sciences · 2025
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Matthew E FalagasAlfa Institute of Biomedical Sciences (AIBS), 9 Neapoleos Street, 151 23 Marousi, Athens, Greece.
Dimitrios S KontogiannisAlfa Institute of Biomedical Sciences (AIBS), 9 Neapoleos Street, 151 23 Marousi, Athens, Greece.
Maria ZidrouAlfa Institute of Biomedical Sciences (AIBS), 9 Neapoleos Street, 151 23 Marousi, Athens, Greece.
Charalampos FilippouSchool of Medicine, European University Cyprus, 2404 Nicosia, Cyprus.ORCID 0000-0002-9324-1641
Giannoula S TansarliDepartment of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA 98195, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This systematic review assessed the global epidemiology of metallo-β-lactamase (MBL)-producing

Indexed as

AcinetobacterAcinetobacter Infectionsbeta-LactamasesDrug Resistance, BacterialAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialGlobal HealthHumansMicrobial Sensitivity TestsAnti-Bacterial Agentsbeta-LactamasesAcinetobacterantimicrobial resistanceimipenemase metallo-β-lactamase (IMP)metallo-β-lactamaseNew Delhi metallo-β-lactamase (NDM)Verona integron-encoded metallo-β-lactamase (VIM)β-lactamase

Identifiers

PMID40559565
PMCPMC12196140

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.